Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
1.240
-0.020 (-1.59%)
At close: Apr 1, 2025, 4:00 PM
1.290
+0.050 (4.03%)
After-hours: Apr 1, 2025, 4:22 PM EDT

Mural Oncology Statistics

Total Valuation

Mural Oncology has a market cap or net worth of $21.36 million. The enterprise value is -$115.34 million.

Market Cap 21.36M
Enterprise Value -115.34M

Important Dates

The last earnings date was Tuesday, March 11, 2025, before market open.

Earnings Date Mar 11, 2025
Ex-Dividend Date n/a

Share Statistics

Mural Oncology has 17.23 million shares outstanding. The number of shares has increased by 1.59% in one year.

Current Share Class 17.23M
Shares Outstanding 17.23M
Shares Change (YoY) +1.59%
Shares Change (QoQ) +0.24%
Owned by Insiders (%) 0.41%
Owned by Institutions (%) 29.06%
Float 12.90M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.15
P/TBV Ratio 0.15
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.84, with a Debt / Equity ratio of 0.06.

Current Ratio 5.84
Quick Ratio 5.53
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -63.57% and return on invested capital (ROIC) is -40.44%.

Return on Equity (ROE) -63.57%
Return on Assets (ROA) -36.68%
Return on Invested Capital (ROIC) -40.44%
Return on Capital Employed (ROCE) -96.55%
Revenue Per Employee n/a
Profits Per Employee -$1.11M
Employee Count 116
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -74.85% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -74.85%
50-Day Moving Average 3.60
200-Day Moving Average 3.45
Relative Strength Index (RSI) 18.94
Average Volume (20 Days) 423,726

Short Selling Information

The latest short interest is 406,115, so 2.36% of the outstanding shares have been sold short.

Short Interest 406,115
Short Previous Month 355,753
Short % of Shares Out 2.36%
Short % of Float 3.15%
Short Ratio (days to cover) 4.53

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -138.26M
Pretax Income n/a
Net Income -128.51M
EBITDA -134.75M
EBIT -138.26M
Earnings Per Share (EPS) -$7.58
Full Income Statement

Balance Sheet

The company has $144.39 million in cash and $8.02 million in debt, giving a net cash position of $136.36 million or $7.92 per share.

Cash & Cash Equivalents 144.39M
Total Debt 8.02M
Net Cash 136.36M
Net Cash Per Share $7.92
Equity (Book Value) 140.50M
Book Value Per Share 8.22
Working Capital 126.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$128.55 million and capital expenditures -$92,000, giving a free cash flow of -$128.64 million.

Operating Cash Flow -128.55M
Capital Expenditures -92,000
Free Cash Flow -128.64M
FCF Per Share -$7.47
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Mural Oncology does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.59%
Shareholder Yield -1.59%
Earnings Yield -611.43%
FCF Yield -612.02%

Analyst Forecast

The average price target for Mural Oncology is $13.00, which is 948.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target $13.00
Price Target Difference 948.39%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 12.43%
EPS Growth Forecast (5Y) -44.54%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a